Sit, stay forever: Americans willing to pay top dollar to keep old dogs
alive
Send a link to a friend
[March 12, 2020]
By Barbara Goldberg
PHILADELPHIA (Reuters) - On a follow-up
visit after Sophie Cortellino's life-saving cardiac procedure, Dr. Anna
Gelzer was delighted and family members were relieved to see her
responding so well. Sophie agreed, her tail wagging excitedly.
As the 9-year-old boxer lay on a metal table, Gelzer tried to push up
her heart rate as part of a stress test following the procedure in
August - a ventricular ablation for an arrhythmia, or irregular
heartbeat, the first performed on a dog in the United States.
"You want a cookie?!" Gelzer teased. "Want to go for a walk?!"
The jagged line tracing Sophie's heartbeat on a monitor spiked
dramatically but she lay calm and alert, and Gelzer grinned with
satisfaction.
Sophie is one of countless aging American dogs undergoing cardiac
treatments, stem cell transplants, tracheal stents, pacemakers and other
sophisticated, expensive procedures to prolong their lives.
Owners of the dogs, many of whom have been around long enough to watch
children grow up and provide support through countless family joys and
traumas, are going to great lengths to prolong their lives, paying bills
of up to $3,000 for stem cell therapy for arthritis and $7,000 for
cardiac procedures like Sophie's.
"Dogs are like a person, a family member," said Gelzer, cardiology
professor at the University of Pennsylvania's School of Veterinary
Medicine in Philadelphia.
Nearly half of the nation’s 77 million pet dogs are aged 6 or older, a
15 percent increase since 1987, according to the American Veterinary
Medical Association.
Larger breed dogs are considered geriatric at 6 years old, smaller
breeds at 7 years old.
Aging dogs contend with many of the same illnesses as elderly humans,
including heart disease, diabetes and senility. Cancer ravages canines
at roughly the same rate as humans, striking nearly half of all dogs
over age 10, experts say.
In Sophie's case, it was an arrhythmia, a condition that has been
treated successfully in humans.
[to top of second column]
|
Sophie, the bulldog, undergoes a checkup after a cardiac ablation
surgery at the School of Veterinary Medicine in Philadelphia,
Pennsylvania, U.S. March 6, 2020. REUTERS/Aleksandra Michalska
In the procedure, a catheter was snaked through blood vessels into
her heart's lower chamber, which pumps oxygen-rich blood to the
body, and trouble spots were cauterized. Gelzer was joined in the
operation by her counterpart who handles human patients, Dr. Cory
Tschabrunn, on the Philadelphia campus.
LOYAL COMPANION
Karen Cortellino, a radiologist, recalled the time nearly a decade
ago when she first met Sophie, an 8-month-old puppy who had been
rejected by another family. Sophie has since helped celebrate
Cortellino's son's college graduation and her daughter's law school
commencement, and dressed up as a member of a family wedding party.
When Cortellino's elderly mother moved into their home in Montville,
New Jersey, Sophie was her sole companion after others left each
morning for work or school.
"They were the best of friends. My mom died last May and Sophie was
there for that," Cortellino said. "I would definitely sacrifice what
I needed to in order for Sophie to have any procedure that would
help her live longer - but well."
When Sophie collapsed last summer and was diagnosed with an
arrhythmia, Gelzer had just won a grant for a clinical trial to test
canine ventricular ablations, so this procedure was free.
The eventual cost is likely to be $5,000-$7,000, Gelzer said, which
Cortellino said she would be "absolutely" willing to pay if Sophie
needs another one.
Her exam completed, Gelzer gladly accepted sloppy kisses from her
patient.
"There is never a doubt that what we do is meaningful," Gelzer said.
"You have to enjoy working with the animals and with the owners. I
like both - very much."
(Reporting by Barbara Goldberg; Editing by Sonya Hepinstall)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |